Skip to main content
logo
Piramal Pharma Limited (NSE:PPLPHARMA)
India flag India · Delayed Price · Currency is INR
184.15
+4.30 (2.39%)
May 11, 2026, 3:30 PM IST

Piramal Pharma Revenue

In the fiscal year ending March 31, 2026, Piramal Pharma had annual revenue of 88.69B INR, down -3.08%. Piramal Pharma had revenue of 27.52B in the quarter ending March 31, 2026, a decrease of -0.08%.

Revenue
88.69B
Revenue Growth
-3.08%
P/S Ratio
2.69
Revenue / Employee
16.20M
Employees
5,476
Market Cap
238.81B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202688.69B-2.82B-3.08%
Mar 31, 202591.51B9.80B11.99%
Mar 31, 202481.71B10.90B15.39%
Mar 31, 202370.82B3.47B5.16%
Mar 31, 202267.34B8.47B14.39%
Mar 31, 2021 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ipca Laboratories95.06B
Emcure Pharmaceuticals92.16B
Alembic Pharmaceuticals72.67B
Gland Pharma61.13B
Ajanta Pharma56.25B
Strides Pharma Science47.26B
NATCO Pharma45.63B
Wockhardt34.84B
Revenue Rankings

Piramal Pharma News

More News